Lear 4166: Parentheses 641 +7.

Rise. The fraudulent order detection service 'O-PLUX' announced that it has been introduced to the food EC site 'Agro MJ', operated by CV Makmur Jaya, which manufactures and sells food based in Southeast Asia. This introduction is a first step based on the collaboration announced recently with Mulai. The company will continue to strengthen its collaboration with Mulai, which provides anti-money laundering and fraud prevention platforms, targeting Southeast Asian markets such as Indonesia and Singapore, leveraging its accumulated technology and know-how in fraud detection.

Lear 2586: Flutta 153 +39.

Surge. Today, it was announced that a premium soft drink using the company's acai will be sold at all locations of the family restaurants Jonathan, considered as positive news. Jonathan has offered menu items using acai in the past, which was one of the popular menu items at that time. Recently, there has been renewed attention on acai, and with customer demand, it has been introduced as a new menu item this time. Additionally, it was also announced that a juice using acai will be available for a limited time at the juice stand "Vegeteria".

Lear 5580: Pro Diraite 1071 +150.

Stop-high. After the trading on the 23rd, it was announced that they will acquire the shares of NN Communications and make it a subsidiary, which has been well received. With the aim of expanding sales channels for the cloud PBX 'INNOVERA' through strengthened Web marketing in the broadband agency business cultivated by NN Communications, they expect further 'One-stop Solutions' to customers by handling installation operations such as LAN construction at the time of introduction in the communication equipment business. They have decided to acquire the shares, judging that they can realize 'Telephone DX'.

Lear 4582: Simbio Pharmaceuticals 228 +3.

Stalemate. The company disclosed data demonstrating the clinical effectiveness of the injection drug brincidofovir (IV BCV) for adenovirus (AdV) infections in severely immunocompromised patients. In a Phase IIa clinical trial of 31 patients, out of 20 patients who achieved disappearance of AdV in the blood, 19 cases (95%) reported favorable clinical progress such as disappearance or improvement of AdV infections as assessed by the trial physicians. Currently, there is no approved antiviral drug for AdV, and due to the lack of safe and effective treatment options, IV BCV is expected to become a new treatment choice.

<5599> S&J 899 +12

Rebound. In the second quarter of the fiscal year ending March 25, the ordinary profit forecast was raised from the previous estimate of 0.116 billion yen to 0.18 billion yen (54.0% increase). There have been delays in the handover of interior work due to office relocation and some delays in recruitment plans, resulting in expenses occurring in the third quarter onwards. However, the full-year performance forecast has been maintained due to the expected occurrence of the same expenses in the third quarter onwards, limiting the positive impact on stock prices.

<7318> Serendip 1547 +197

Marked rebound. The company announced the acquisition and subsidiary formation of Excel Group, which develops and manufactures resin molded products such as automotive parts ducts. Excel consists of a total of 9 companies, including 5 domestic and 4 overseas companies, making it the largest M&A since the company's establishment. Following Iwai, this is a roll-up type M&A based on functionality and technology, with high compatibility with Mitsuya Kogyo, which develops and manufactures lightweight and quiet automotive interior and exterior products using resin molding. Expectations are high for synergy effects, and Excel's participation in the group with overseas production bases will lead to the company's global evolution in a discontinuous manner.